SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on June 18, 2021. The report covers an event occurring on the same date. The company is incorporated in California and operates in the medical products sector.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
There are no material financial changes reported in this document. The sole event disclosed is the posting of an updated corporate investor deck on the company's website.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary on risks, or contingencies. It serves only to direct investors to the updated corporate deck available at the company's investor relations website for further information.
Key Facts for Investor Verification
- The company name in the metadata (Vivani Medical, Inc.) differs from the registrant in the filing (Second Sight Medical Products, Inc.); verify the correct entity.
- Review the updated corporate deck linked in the filing for the latest strategic and financial details.
- Confirm the trading symbols EYES (Common Stock) and EYESW (Warrants) on NASDAQ.
- Note that Scott Dunbar signed the report as Acting Chief Executive Officer.